Our Mission

To continually deliver innovative solutions to improve the lives of our patients and their families

Trust

is where everything begins, built by listening deeply to what life is really like for our patients and taking action in meaningful, practical ways.

Expertise

is our foundation of knowledge and experience, shared by our scientists, our medical and commercial teams, our healthcare professionals, our patients and our carers. It's where breakthroughs emerge, and its real value is in how we use our expertise to improve patient lives, today.

Positivity

is the fuel that helps us overcome the next challenge. Embracing the tough days and celebrating the small wins, brings us closer to delivering on our mission.

Collaboration

is when we work together to get the best results. When patients, clinicians, partners and internal teams co-create from the start, ideas move faster, our perspective is enhanced and more impactful solutions are delivered.

Innovation

is about discovering a new pathway that moves our work forward. We are excited by what's possible and we are guided by what's needed for our patients to live fuller lives.

Meet our Team

Simon Lawrence - man in dark blazer over light shirt, seated at desk

Simon Lawrence

Vice President

Sarah Dolan Ph.D. - smiling woman, white top, neutral background

Sarah Dolan Ph.D.

Associate Director

Lisa Fisher - woman with blonde wavy hair and scarf, smiling

Lisa Fisher

Your local representative for the UK

Our History

Galsana began as a specialist Medical Nutrition team within the wider Galen group of companies

Man standing beside a Galen company sign outside an industrial facility in a vintage photograph
Two women at a Galen award ceremony, one holding a large cheque and the other holding a glass trophy
Attendees seated at round tables during a Galen business meeting, with a Thank You slide projected on screen

Galen was established in 1968 and is headquartered in Craigavon, Northern Ireland. From the start, the company has worked alongside healthcare professionals and patients to advance human health across multiple therapy areas, geographies and markets.

Through the acquisition of POA Pharma Scandinavia AB in 2017, Galen’s medical nutrition division was born. Over time, the team embraced market-leading technologies and expanded their specialist knowledge and portfolio to become specialists in metabolic products and services.

In 2026, Galsana launched as a standalone brand with its own identity and purpose. Our role is clear: to bring fast-moving innovations to patients with metabolic conditions, their carers and families, and to support fuller lives.

Today, Galsana actively pursues new global opportunities, from portfolio enhancement and commercial partnerships to scientific and technological breakthroughs. Everything we do is driven by a patient first innovation approach, so we can deliver meaningful impact for patients worldwide.

Our Community

At Galsana, patient first innovation starts with community

A family laughing together outdoors on a picnic blanket
Smiling woman in a tan cardigan engaged in conversation at a professional conference or seminar
Three colleagues engaged in a business meeting around a conference table with laptops and notebooks

We understand that every journey with a metabolic condition is unique. That's why we listen deeply to what life is really like, then turn that insight into practical support that fits real days, real routines and real goals.

Trust is where we start, earned through listening, follow-through, and treating every patient, carer and family with authenticity and respect. Powered by shared expertise and a positive mindset, we collaborate from day one and keep innovating with purpose, evolving solutions that offer more choice and help people live fuller lives.

Building on this patient insight, we bring together scientists, clinicians, partners, and our medical and commercial teams to co-create from the outset. This shared perspective builds our community where progress is practical and partnership is genuine.